Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent
Loading...
Date
2023-05-26
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Science and Business Media LLC
Abstract
binding analysis for five strains (Omicron, BJ.
Description
Keywords
Outbreak, Case fatality rate, Dexamethasone, Coronavirus disease 2019 (COVID-19), Drug, Medicine, Virology, Pandemic, 2019-20 coronavirus outbreak, Environmental health, Intensive care medicine, Pharmacology, Internal medicine, Infectious disease (medical specialty), Disease, Population, type of access: open access
Citation
Liu Dongsheng, Saeed Aamir, Majaz Sidra, Ahmad Bashrat, Ahmad Ashfaq, Xie Yingqiu. (2023). Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent. Journal of Translational Medicine. https://doi.org/10.1186/s12967-023-04186-4